Ethical oxymora for risk assessment practitioners.
D016265:Conflict of Interest; D003625:Data Collection; D064420:Drug-Related Side Effects and Adverse Reactions; D004467:Economics; D004651:Employment; D004813:Epidemiology; D004995:Ethics, Professional; D005069:Evaluation Studies as Topic; D005104:Expert Testimony; D035082:Federal Government; D005378:Financial Support; D005607:Fraud; D006076:Government; D015386:Hazardous Substances; D006805:Human Experimentation; D006801:Humans; D007221:Industry; D033181:Information Dissemination; D007255:Information Services; D033183:Interdisciplinary Communication; D007400:Interprofessional Relations; D016273:Occupational Exposure; D010380:Peer Review; D011057:Politics; D011634:Public Health; D012015:Reference Standards; D012107:Research Design; D012108:Research Personnel; D012306:Risk; D012586:Science; D015871:Scientific Misconduct; D013219:State Government; D014481:United States; D014495:Universities
Bioethics and Professional Ethics; Biomedical and Behavioral Research; Empirical Approach